Monday, September 13, 2010

9/13 Health News from Medical News Today

     
    Health News from Medical News Today    
   
West Nile Virus Positive Mosquitoes Identified In 20 Connecticut Towns
September 12, 2010 at 10:00 AM
 
Twenty Connecticut towns are reported to have West Nile Virus positive mosquitoes, Department of Public Health Commissioner Dr. J. Robert Galvin informs. Connecticut's Mosquito Management Program announced that a resident of Clinton recently tested positive for WNV (West Nile Virus) and has been admitted to hospital. The elderly resident showed symptoms of fever, severe headache, weakness and fatigue during the first month of September and is in hospital for meningitis. Laboratory tests confirmed the presence of WNV antibodies...


   
   
GlaxoSmithKline And Genmab Announce Start Of Ofatumumab Phase III Combination Study In Non-Hodgkin's Lymphoma
September 12, 2010 at 5:00 AM
 
GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced the start of a Phase III study in patients with indolent B-cell non-Hodgkin's lymphoma (B-NHL) who did not respond to or progressed during, or within 6 months of a rituximab containing regimen. Under the terms of Genmab's collaboration with GlaxoSmithKline (GSK), Genmab will receive a milestone payment of approximately DKK 116 million (approximately USD 20 million), triggered by the treatment of the first patient in the study...


   
   
Baylor Health Care System Selects Cardinal Health As Preferred Medical Products Supplier
September 12, 2010 at 5:00 AM
 
Cardinal Health announced that Baylor Health Care System has selected the company as its preferred provider of medical product supply chain services for its hospitals, specialty facilities and other care locations. Under the terms of the agreement, Cardinal Health will provide medical product supply chain services to Baylor's network of health care facilities, with a goal of reducing inventory costs and improving safety for patients...


   
   
GSK And BJD Collaborate On A New Educational Programme To Reduce Global Burden Of Joint Pain
September 12, 2010 at 5:00 AM
 
The Bone and Joint Decade (BJD) international initiative and GlaxoSmithKline (GSK) announced the launch of the LIBERATE™ joint pain management programme during the BJD's World Conference in Lund, Sweden. The BJD, which is endorsed by the United Nation's World Health Organisation, and GSK have partnered to develop the global programme that provides information on practical and clinically proven techniques that people can use to self-manage their joint pain...


   
   
Quintiles Central Laboratory In Japan Receives Cap Accreditation
September 12, 2010 at 5:00 AM
 
Quintiles announced that its new lab in Tokyo, Japan has received accreditation from the College of American Pathologists (CAP), joining the largest network of fully harmonized, CAP-accredited central labs in the world. "CAP accreditation has become the international gold standard for quality, and Quintiles is committed to delivering quality laboratory services that meet complex regulatory requirements in the New Health landscape," said Thomas Wollman, Senior Vice President, Quintiles Global Central Laboratories...


   
   
Ed Randall's Fans For The Cure Charity Launches BLUETEMBER Program To Raise Prostate Cancer Awareness
September 12, 2010 at 4:00 AM
 
Ed Randall's Fans For The Cure charity is launching its first ever BLUETEMBER program with special events at cities around the country to coincide with National Prostate Cancer Awareness Month. BLUETEMBER events included a free PSA screening during the ORIOLES-YANKEES game at Yankee Stadium on September 7th. Future events include a Prostate Cancer Awareness Night at the Newark (NJ) Bears on September 10th, and two events in Chicago - the Sea Blue Walk for Prostate Cancer on September 19th and Rock Out 4 Cancer concert on September 20th...


   
   
Anacor Pharmaceuticals Establishes Collaboration To Discover New Medicines For Animal Health
September 12, 2010 at 4:00 AM
 
Anacor Pharmaceuticals today announced the establishment of a research agreement with Eli Lilly and Company to create and develop new therapeutics for animal health. The collaboration takes advantage of Anacor's boron chemistry platform and drug research capabilities with the goal of advancing innovative therapeutic compounds to fill significant unmet needs in both companion and food animals...


   
   
UIC's Institute For Juvenile Research Celebrates Centennial
September 12, 2010 at 4:00 AM
 
The University of Illinois at Chicago College of Medicine's Institute for Juvenile Research will celebrate its centennial anniversary Oct. 1. The celebration, at the UIC Student Center West, 828 S. Wolcott Ave., will highlight the neuroscience and psychosocial research of the institute and how these efforts have transformed public policy to improve the well-being of children and their families. "We need to celebrate and honor a century-old institute that has guided Chicago, Illinois, and the United States on how to nurture and protect our most valuable resource -- our children," says Dr...


   
   
Researchers Invited To Apply For First $50,000 AACN Impact Research Grant To Address Gaps In Clinical Bedside Research
September 12, 2010 at 4:00 AM
 
The American Association of Critical-Care Nurses announces the first $50,000 AACN Impact Research Grant to support clinical inquiry and drive change in high acuity and critical care nursing practice. The new AACN grant funds priority projects that address gaps in clinical research at the organization or system level and translation of these findings for the bedside clinician...


   
   
RCGP Update On Health White Paper, England
September 12, 2010 at 4:00 AM
 
The view of the RCGP College Council is that the needs of patients and quality of care must remain absolutely central to any changes to the NHS in England outlined by the Government in the Health White Paper. Over the past six weeks the College has engaged in a debate with its members across the UK around the White Paper consultation. At its meeting today, the Council welcomed the opportunity to discuss and shape future Government policy with the Department of Health...


   
   
Hospira And Smiths Medical To Co-Promote Infusion Pumps And Develop A Standardized Safety Monitoring And Reporting Solution Across Infusion Systems
September 12, 2010 at 4:00 AM
 
Hospira, Inc. (NYSE: HSP - News), a leading provider of clinical information and medication delivery technologies, and Smiths Medical, a leading global medical device manufacturer,announced a commercial collaboration and co-development agreement for infusion pump systems. Effective immediately, Hospira and Smiths Medical will co-promote Hospira's Symbiq™ and Plum A+™ general infusion pumps with Hospira MedNet™ safety software, and Smiths Medical's Medfusion™ syringe pumps with PharmGuard® Medication Safety Software...


   
   
Merck Receives Approval From FDA For Expanded Indications For Atypical Antipsychotic Medication SAPHRIS® (asenapine) Sublingual Tablets
September 12, 2010 at 4:00 AM
 
Merck announced that the U.S. Food and Drug Administration (FDA) has approved two supplemental new drug applications (sNDA's) for SAPHRIS® (asenapine) sublingual tablets to expand the product's indications. SAPHRIS is now indicated for the treatment of schizophrenia in adults, as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, and as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults...


   
   
FDA Advisory Committee Recommends Approval Of Forest Laboratories' Ceftaroline Fosamil For The Treatment Of Community Acquired Bacterial Pneumonia
September 12, 2010 at 4:00 AM
 
Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI)...


   
   
Johnson & Johnson Aims To Help Up To 120 Million Women And Children Each Year Through Five-Year Commitment To U.N. Millennium Development Goals
September 12, 2010 at 4:00 AM
 
Johnson & Johnson announced the launch of Every Mother, Every Child, a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations' April 2010 call for a renewed effort to achieve the Millennium Development Goals (MDGs) of reducing mortality in women and children by 2015. Every Mother, Every Child aims to help as many as 120 million women and children each year over the next five years, and represents a significant commitment of grants, medicine donations, research and development...


   
   
Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Therapy And First In A New Class
September 12, 2010 at 4:00 AM
 
The Russian health authority, the Federal Service on Surveillance in Healthcare and Social Development, has granted approval for Gilenya® (fingolimod) 0.5 mg once-daily oral therapy for the treatment of relapsing remitting multiple sclerosis (MS). Approximately 85% of patients with MS are estimated to have the relapsing remitting form at the onset of disease. Russia is the first country to approve Gilenya, providing a new treatment option offering significant efficacy for patients in the convenience of an oral capsule. Novartis expects to launch Gilenya in Russia in early 2011...


   
   
AAP Celebrates 5th Anniversary Of Neonatal Resuscitation Program In China
September 12, 2010 at 4:00 AM
 
The American Academy of Pediatrics (AAP) is celebrating the fifth anniversary of an international partnership that has taught essential neonatal resuscitation skills to birth attendants in China, saving an estimated 90,000 infants who would have died or been seriously injured from birth asphyxia. According to national statistics from five years ago, more than one in five infant deaths in China were a result of birth asphyxia, making it the leading cause of mortality among children younger than 5 in Chinese cities...


   
   
UNICEF Announces Nominees For The 2010 International Children's Day Of Broadcasting (ICDB) Awards
September 12, 2010 at 4:00 AM
 
UNICEF last week announced the nominees for the International Children's Day of Broadcasting (ICDB) Awards. The awards are given by UNICEF for outstanding commitment to the ICDB by television and radio broadcasters. The winner of the 2010 ICDB Awards will be announced at an awards ceremony dinner at The Modern on 2 November 2010 in New York. The nominees each won a regional competition and now go on to compete for global honours...


   
   
UNISON Carers Shine Spotlight On Low Pay In Homecare, UK
September 12, 2010 at 4:00 AM
 
Three carers, employed by a private company in Norfolk, will today give evidence to the Low Pay Commission in London, to tell of their fight to tackle pay anomalies that left them struggling to earn the minimum wage for the hours they worked. The carers were paid a set amount per call, rather than a straightforward hourly rate. Not paying travel time is commonplace in the UK care sector, and can see staff lose up to fifteen minutes pay for every hour they work. With UNISON's backing, the women won their battle to be paid for travel time, but others in the sector are still waiting...


   
   
New Funds Support Rural Hospitals' Switch To Electronic Health Records
September 12, 2010 at 4:00 AM
 
HHS Secretary Kathleen Sebelius announced nearly $20 million in new technical support assistance to help critical access and rural hospital facilities convert from paper-based medical records to certified electronic health record (EHR) technology. Some 1,655 critical access and rural hospitals in 41 states and the nationwide Indian Country, headquartered in the District of Columbia, stand to benefit from this assistance, which can help each of them qualify for substantial EHR incentive payments from Medicare and Medicaid...


   
   
Medtronic Announces First European Implant Of New Drug-Eluting Stent At Southampton General Hospital, UK
September 12, 2010 at 4:00 AM
 
Medtronic, Inc. (NYSE: MDT), has announced the CE (Conformité Européene) mark and international launch of the Resolute Integrity Stent System for the treatment of coronary artery disease, a leading cause of death and poor quality of life. Now available in the UK, and implanted for the first time in Europe at Southampton General Hospital, the Resolute Integrity Stent System features a novel drug-eluting coronary stent with superior deliverability the ability of the device to traverse the patient's vasculature and reach the blockage in the heart artery...


   
   
Nursing's Centralized Application Service Expands To Accommodate Applicants To Both Graduate And Entry-Level Nursing Programs
September 12, 2010 at 4:00 AM
 
Today, the American Association of Colleges of Nursing (AACN) is pleased to announce that NursingCAS - the nation's only centralized service for students applying to nursing programs - is now accepting applications to graduate nursing programs. Students applying to any level of nursing program - from the doctorate to the diploma - may now submit applications to participating schools across the country through NursingCAS. When the service initially launched in March 2010, only students applying to entry-level nursing programs could benefit from this Web-based system...


   
   
Cardinal Health Helps Hospitals Lower Pharmaceutical Costs As National Statistics Show Increased Drug Spend Among Acute Care Facilities
September 12, 2010 at 4:00 AM
 
Hospital pharmacies managed by Cardinal Health reduced their overall drug spend by 1.3 percent in 20091, while average pharmaceutical costs in non-federal acute care hospitals increased by 3 percent in that same period2. Through its Pharmacy Solutions business, Cardinal Health's team of more than 1,000 licensed hospital pharmacists manage nearly two hundred hospital pharmacies across the United States and Puerto Rico...


   
   
Glaucoma Research Foundation Hosts Catalyst Meeting
September 12, 2010 at 4:00 AM
 
Scientists from around the world will gather today to discuss new research ideas that could lead to a cure for glaucoma. "Bringing together leaders in the field to inspire and challenge each other will result in new ideas to attack this blinding disease" said H. Dunbar Hoskins, Jr., MD, founding board member of Glaucoma Research Foundation and Moderator for the meeting. "Our meeting goal is to identify ideas that could impact treatment within five years...


   
   
New GE Giraffe Shuttle Eases Babies' Journeys Within Hospital
September 12, 2010 at 4:00 AM
 
GE Healthcare (NYSE:GE) has received US Food and Drug Administration (FDA) clearance to market the Giraffe Shuttle transportable power source with its Giraffe® and Panda® families of incubators and warmers for newborn babies, enabling them to be used for intra-hospital transport. The Giraffe Shuttle, combined with the bed, helps weak babies focus their energy on healing and growing instead of on managing the stress of exposure to cold temperatures and excessive handling...


   
   
Covidien Supports FDA's Patient Safety Efforts For Gadolinium-Based Contrast Agents
September 12, 2010 at 4:00 AM
 
Covidien (NYSE:COV), a leading global provider of healthcare products, announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or chronic, severe kidney disease. In November 2009, Covidien's Mallinckrodt business voluntarily contraindicated the use of its Optimark(TM) (gadoversetamide injection) in MRI procedures involving the same small group of patients with severe renal impairment...


   
   
Diabetes Information In Twenty Languages
September 12, 2010 at 3:00 AM
 
Leading health charity Diabetes UK now has a range of diabetes literature in twenty different languages. The charity has focussed on materials in many Eastern European languages as well as Chinese, Somali, Arabic, and the main South Asian languages. The charity has done this to ensure communities at high risk of diabetes can access this vital information. Diabetes UK also hopes the information will raise awareness of the condition and meet the needs of people with diabetes from Black, Asian and minority ethnic communities living in the UK...


   
   
Molina Healthcare Of Texas Begins Administering CHIP Program In Rural Areas
September 12, 2010 at 3:00 AM
 
Molina Healthcare of Texas announced today that it has begun arranging healthcare services for approximately 63,700 low-income children and pregnant women in 174 predominantly rural counties through Texas' Children's Health Insurance Program (CHIP) and CHIP Perinatal Program. The contract is held by Molina Healthcare of Texas's newly formed, wholly owned subsidiary, Molina Healthcare of Texas Insurance Company, which has been approved to operate as an exclusive provider organization in the service area. Molina Healthcare of Texas will administer the contract on behalf of its subsidiary...


   
   
Nearly 400 Medicines And Vaccines In Development To Fight Infectious Diseases
September 12, 2010 at 3:00 AM
 
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review. Scientists have made huge strides against infectious diseases, which until the 1920s were the leading cause of death in the United States...


   
   
World's First Transcontinental Anesthesia
September 12, 2010 at 3:00 AM
 
Videoconferences may be known for putting people to sleep, but never like this. Dr. Thomas Hemmerling and his team of McGill's Department of Anesthesia achieved a world first on August 30, 2010, when they treated patients undergoing thyroid gland surgery in Italy remotely from Montreal. The approach is part of new technological advancements, known as 'Teleanesthesia', and it involves a team of engineers, researchers and anesthesiologists who will ultimately apply the drugs intravenously which are then controlled remotely through an automated system...


   
   
Brain Tunnelgenix Technologies Receives FDA Approval For Abreu BTT™ System For Continuous Temperature Monitoring
September 12, 2010 at 3:00 AM
 
Brain Tunnelgenix Technologies Corp. (BTT Corp.) announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT™ 700 System for continuous temperature monitoring. The Abreu BTT 700 System sensor is approved for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring...


   
   
TRUST Trial Results For Remote Monitoring Of ICD System Function Published In Circulation Arrhythmia And Electrophysiology
September 12, 2010 at 3:00 AM
 
BIOTRONIK, pioneer of the industry's first and most advanced wireless remote monitoring technologies and leading manufacturer of premium implantable cardiac devices, announced that the results from the landmark TRUST Trial (Lumax-T/Lumos-T Safely Reduces Routine Office Device Follow-up) were recently published online and will be published in the October 13, 2010 issue of Circulation Arrhythmia and Electrophysiology...


   
   
BSD Medical's China Distributor Orders Two BSD-2000 Hyperthermia Systems
September 12, 2010 at 3:00 AM
 
BSD Medical Corporation (NASDAQ: BSDM) (the "Company" or "BSD") announced today that Dalian Orientech Co. Ltd ("Orientech"), the Company's exclusive China distributor, has ordered two BSD-2000 Hyperthermia Systems (BSD-2000). The BSD-2000 System utilizes BSD's proprietary synchronous phased array technology to non-invasively target therapeutic heating (hyperthermia) to certain cancerous tumors, including those located deep within the body...


   
   
Aesculap Implant Systems, LLC Receives FDA 510(k) Clearance For The S4(R) Cervical Occipital Plating System
September 12, 2010 at 3:00 AM
 
The Aesculap Implant Systems S4 Cervical Occipital Plating System has been cleared for marketing by the FDA under K100147. The agency began review of the Special 510(k) on January 19, 2010 and received the Substantial Equivalence determination on July 23, 2010. The S4 Cervical Occipital Plating System is used to promote spinal fusion of the cervical and thoracic spine (C1-T3) and occipito-cervico-thoracic junction (occiput-T3) in patients with degenerative disease or fracture. Source: Aesculap Implant Systems, LLC B...


   
   
Tornier Announces Preliminary Clinical Results For First Series Of Patients Treated With Pyrocarbon Shoulder Prostheses
September 12, 2010 at 3:00 AM
 
Tornier, Inc., a global leader in extremity and sports medicine orthopaedics, announced the successful early clinical results of the first seven pyrocarbon shoulder prostheses that were implanted between April 2009 and December 2009. For numerous orthopedic indications, pyrocarbon implants have demonstrated very favorable implant-on-bone and implant-on-soft tissue fatigue and wear characteristics, leading to reduced patient pain and shorter recovery times...


   
   
The Benefits Of Crospon's EndoFLIP(R) System Presented At International Obesity Surgery Congress 2010
September 12, 2010 at 3:00 AM
 
Crospon, an Irish medical device developer based in Galway, has announced results of a study presented at the 15th Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO 2010), in Long Beach, CA. The study which took place at the Speciality Surgery Center of Fort Worth, TX, a Center of the AIGB True Results clinical network, the largest gastric band placement network in the world, under the direction of Principal Investigator Dr. Robert G...


   
   
Seaside Therapeutics Reports Positive Data From Phase 2 Study Of STX209 In Autism Spectrum Disorders
September 12, 2010 at 3:00 AM
 
Seaside Therapeutics, Inc. announced positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p "We observed marked improvement in the majority of patients treated in the STX209 autism spectrum disorders study, including reductions in agitation and tantrums," said Craig A. Erickson, M.D...


   
   
Team Of Experts Releases Guidance On Safe Deployment Of Transgenic Sorghum
September 12, 2010 at 3:00 AM
 
Today an article in Nature Biotechnology, authored by an expert panel from academia, government, industry, and non-profit research, provides guidance on the steps required for safe deployment of genetically modified (GM) sorghum. The panel considered nutritionally enhanced GM sorghum developed for cultivation in Africa, where there is a potential for gene flow to wild species (see Hokanson et al., "Biofortified sorghum in Africa: using problem formulation to inform risk assessment")...


   
   
More Than 690,000 Americans Have Already Been Vaccinated Against The Flu This Season, SDI Reports
September 12, 2010 at 3:00 AM
 
More than 690,000 Americans have already received this season's flu vaccine from their doctor, according to SDI's VaccineTrack® data through Sept. 4. VaccineTrack® provides syndicated weekly vaccine usage by physicians based on medical office electronic healthcare reimbursement claims data. The U.S. Centers for Disease Control and Prevention (CDC) recently announced an unprecedented campaign to combat seasonal flu through a universal vaccination strategy...


   
   
Five American Health Care Professionals Arrested In Zimbabwe
September 12, 2010 at 3:00 AM
 
Five Americans, two of them doctors, two nurses and an organizer who worked with AIDS patients and orphans in Zimbabwe have been arrested for not having appropriate medical licenses, according to their attorney, Jonathan Samukange. Chairwoman of an AIDS program run by the Allen Temple Baptist Church, Oakland, California, Gloria Cox is among those arrested, the lawyer said - the organization supports AIDS orphans and people with AIDS in Zimbabwe. The church serves a mainly African-American congregation. The five were arrested on Thursday and have remained in jail since...


   
   
How Do Sport Medicine Doctors Make Return-to-Play Decisions?
September 12, 2010 at 3:00 AM
 
When is it appropriate for an injured athlete to return to competition? A new three-step framework provides team physicians and other sport medicine clinicians with guidance on making complex decisions about return to play, reported in the September Clinical Journal of Sport Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy...


   
   
Dr. Maya Spaeth Joins Nationwide Children's Hospital Plastic Surgery Team And Brings New Service To Program
September 12, 2010 at 3:00 AM
 
Maya Spaeth, MD, joined Nationwide Children's Hospital in September as co-director of the Hand, Microsurgery and Brachial Plexus Program within the section of Plastic Surgery. She comes to Nationwide Children's from Loma Linda University in Loma Linda, California where she served as an Assistant Professor of Plastic Surgery. The addition of Dr. Spaeth brings several entirely new services to Nationwide Children's Hospital including Brachial Plexus...


   
   
Program To Improve Palliative Care Falls Short Of Hopes
September 12, 2010 at 3:00 AM
 
There may be no simple one-size-fits-all approach to improving end-of-life care in ICU settings, according to a recent study from some of the world's leading researchers in palliative care...


   
   
EU Decision On Laboratory Animals
September 12, 2010 at 3:00 AM
 
Welcoming the announcement of a new EU Directive aimed at reducing the number of animals used in laboratory experiments, tightening controls over such procedures and harmonising improved standards of care throughout Europe the British Veterinary Association's President Professor Bill Reilly said: "The UK already has a firm commitment to the principle of the Three Rs - replace refine, reduce - and the BVA is pleased that MEPs have voted to firmly anchor this principle in the new legislation so that the practice can be implemented across the EU...


   
   
Foiling Terror Attacks: New CCTV Technology
September 12, 2010 at 3:00 AM
 
VTT Technical Research Centre of Finland is developing image processing technology that will improve surveillance of abandoned luggage in public places Numerous CCTV systems are in use in public places which have the capacity to gather large amounts of image material. For the time being, however, there are no effective ways to analyse the mass of video data automatically and recognise potential risk situations in advance. VTT is involved in an EU research project aimed at developing IT solutions to this end...


   
     
 
This email was sent to medicalblogsyahrul@gmail.com.
Delivered by Feed My Inbox
230 Franklin Road Suite 814 Franklin, TN 37064
Create Account
Unsubscribe Here Feed My Inbox
 
     
Share on :

0 comments:

Post a Comment

 
© Copyright medical information portal 2011 - Some rights reserved | Powered by Blogger.com.
Template Design by Herdiansyah Hamzah | Published by Borneo Templates and Theme4all